A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Stuart D Shanler, MD
Aclaris Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aclaris Investigational Site
Glendale, Arizona, United States
- Aclaris Investigational Site
Fort Smith, Arkansas, United States
- Aclaris Investigational Site
Encinitas, California, United States
- Aclaris Investigational Site
Los Angeles, California, United States
- Aclaris Investigational Site
Denver, Colorado, United States
- Aclaris Investigational Site
Omaha, Nebraska, United States
- Aclaris Investigational Site
Albuquerque, New Mexico, United States
- Aclaris Investigational Site
Rochester, New York, United States
- Aclaris Investigational Site
High Point, South Carolina, United States
- Aclaris Investigational Site
Knoxville, Tennessee, United States
- Aclaris Investigational Site
Nashville, Tennessee, United States
- Aclaris Investigational Site
College Station, Texas, United States
- Aclaris Investigational Site
Houston, Texas, United States
- Aclaris Investigational Site
Salt Lake City, Utah, United States
- Aclaris Investigational Site
Lynchburg, Virginia, United States
- Aclaris Investigational Site
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jul 2017
- Primary completion
- 1 Mar 2018
- Completion
- 1 Mar 2018
- Last update posted
- 9 Apr 2019
- Registered enrollment
- 159
- Registry id
- NCT03278028
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.